Distributed Control System Market worth $29.32 billion by 2030
Browse in-depth TOC on "Distributed Control System Market"
298 - Tables
70 - Figures
295 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=239430160
Continuous process application segment is projected to account for the largest market share in 2030.
The continuous process segment is likely to account for the largest share of the Distributed Control System Market in 2030, as complex systems need constant monitoring, high levels of reliability, and the ability to run continuously. DCS is deployed in industries where continuous processing is required, including oil & gas, power generation, chemicals, and water treatment, all of which require real-time control and system stability for safe and efficient delivery. The need for automated centralized control across complex operations is what DCS offers. With advances in remote monitoring, predictive maintenance, and established integration with IoT and AI technologies, the capabilities of DCS are substantially superior. Therefore, DCS systems have become even more critical to industries that are processing (24/7). As energy security, emissions reduction, and regulatory compliance become higher priorities for enterprises, they are leading the charge for DCS systems, especially for those organizations that rely on continuous processing systems.
Services segment is expected to record the highest CAGR in the Distributed Control System Market from 2025 to 2030.
As of 2024, DCS service adoption among industries, such as power generation, oil & gas, and chemicals, is increasing. Several industries focus on investing in DCS services as an option to increase their system reliability and efficiency. Services include consulting and engineering, support, maintenance, and other features that are often implemented faster than new installations while offering flexible and scalable solutions for their clients. The push for predictive maintenance, cybersecurity compliance, and remote diagnostics has sped up the demand for value-added services. This trend will continue across all global markets, as companies continue to focus on ensuring minimal downtime, optimum outages, and limited operational costs.
Asia Pacific segment is anticipated to be the fastest-growing region during the forecast period.
In 2024, Asia Pacific is expected to grow the fastest in the global Distributed Control System Market. This region encompasses large countries, such as China, Japan, India, and Australia, as well as other countries in Southeast Asia. The reason for Asia Pacific being the largest portion of the global market is due to the high adoption of renewables, as well as grid modernization seen across major economies. Countries within this region also support the transition through investments in smart grids, digital energy infrastructure, and decentralized energy systems. Several national programs support efforts, including China's investment in a UHV grid, India's non-fossil energy target of 500 GW, and Southeast Asia's focus on regional grid connectivity. Utilities, power, and manufacturing industries spur the growth of the Distributed Control System Market. The overall trend toward industrial automation remains a key opportunity for market growth across the region.
Key Players
Some major players in the Distributed Control System Market are GE Vernova (US), Honeywell International Inc. (US), Siemens (Germany), Hitachi Ltd. (Japan), and Schneider Electric (France). Major strategies adopted by these players include acquisitions, product launches, agreements, partnerships, and expansions.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=239430160
Honeywell International (US)
Honeywell International Inc. is a global manufacturing company. The company provides various products and services, including aircraft systems, building controls, industrial automation (distributed control systems), and advanced materials. It serves industries such as aviation, energy, manufacturing, and logistics. It operates through four main business segments: Aerospace Technologies, Industrial Automation, Building Automation, Energy and Sustainability Solutions, and Corporate and All Other. Under its Performance Materials and Technologies segment, Honeywell International Inc. offers distributed control systems. This segment develops process technologies and manufactures advanced materials used in refrigerants, blowing agents, pharmaceuticals, and industrial applications. It offers automation control systems, safety systems, field instrumentation, and connected plant solutions across multiple industries. It offers various DCS solutions, such as hardware support, Human Machine Interface (HMI) services, and system support. In recent years, Honeywell International Inc. has made several strategic decisions, such as partnerships and product launches, to position itself for growth in the Distributed Control System Market. For example, in September 2024, Honeywell International Inc. partnered with USA BioEnergy to implement its Experion PKS Distributed Control System (DCS) and safety solution at USA BioEnergy's Bon?Wier sustainable aviation fuel (SAF) facility in Texas. The company has a geographical presence across 77 countries, with a strong presence in the US. It is also operational in Europe and other regions.
Schneider Electric (France)
Schneider Electric specializes in the digital transformation of energy management and automation. The company specializes in industrial automation, energy management, digital automation, sustainability, innovation, digitalization, artificial intelligence, engineering, cybersecurity, renewables, digital supply chain, manufacturing, electrification, building management systems, power systems and services, microgrids, industrial software design and optimization, solar and energy storage, and software-centric automation & solutions. The company operates its business through two business segments, namely, Energy Management and Industrial Automation. It serves the Distributed Control System Market through its Industrial Automation segment.. In recent years, it has made several strategic decisions, such as collaborations, to position itself for growth in the Distributed Control System Market. For example, in February 2024, Schneider Electric collaborated with Intel and Red Hat to create the Distributed Control Node (DCN). This system uses software to control industrial processes and combines computer technology with factory operations. The company has opened its newest facility in Raleigh, North Carolina. RaleighHub, its new 65,000-square-foot hybrid building, can house over 400 employees. The RaleighHub hybrid space includes innovative research and development labs, customer training rooms, conference areas, collaboration spaces, and employee workstations. The company has a worldwide presence in over 100 countries across Europe, the Middle East & Africa, Asia Pacific, South America, and North America, with a broad supply chain that integrates 200 factories with 90 distribution centers.
For more information, Inquire Now!
Related Reports:
DERMS Market
Power SCADA Market
Get access to the latest updates on Distributed Control System Companies and Distributed Control System Industry
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress Ave.Suite 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@marketsandmarkets.comVisit Our Website: https://www.marketsandmarkets.com/
Logo - https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/distributed-control-system-market-worth-29-32-billion-by-2030--marketsandmarkets-302511800.html
SOURCE MarketsandMarkets
Error al recuperar los datos
Inicia sesión para acceder a tu cartera de valores
Error al recuperar los datos
Error al recuperar los datos
Error al recuperar los datos
Error al recuperar los datos
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
XAI Madison Equity Premium Income Fund Declares its Monthly Distribution of $0.060 per Share
CHICAGO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- XAI Madison Equity Premium Income Fund (the 'Fund'), has declared its regular monthly distribution of $0.060 per share on the Fund's common shares (NYSE: MCN) payable on September 2, 2025. The amount represents no change from the previous month's distribution amount. As mentioned in previous distribution declarations, the Fund has changed its distribution frequency from quarterly to monthly, which went into effect with the April 1, 2025 declaration. XA Investments believes this change enables investors to better manage their cash flow needs. Ex-Dividend Date August 15, 2025 Record Date August 15, 2025 Payable Date September 2, 2025 Amount $0.060 per share Change from Previous Month No Change The following dates apply to the declaration: Common share distributions may be paid from net investment income (regular interest and dividends), capital gains and/or a return of capital. The specific tax characteristics of the distributions will be reported to the Fund's common shareholders on Form 1099 after the end of the 2025 calendar year. Shareholders should not assume that the source of a distribution from the Fund is net income or profit. For further information regarding the Fund's distributions, please visit . The Fund's net investment income and capital gain can vary significantly over time; however, the Fund seeks to maintain more stable common share quarterly distributions over time. The Fund's final taxable income for the current fiscal year will not be known until the Fund's tax returns are filed. As a registered investment company, the Fund is subject to a 4% excise tax that is imposed if the Fund does not distribute to common shareholders by the end of any calendar year at least the sum of (i) 98% of its ordinary income (not taking into account any capital gain or loss) for the calendar year and (ii) 98.2% of its capital gain in excess of its capital loss (adjusted for certain ordinary losses) for a one-year period generally ending on December 31 of the calendar year (unless an election is made to use the Fund's fiscal year). In certain circumstances, the Fund may elect to retain income or capital gain to the extent that the Board of Trustees, in consultation with Fund management, determines it to be in the interest of shareholders to do so. The common share distributions paid by the Fund for any particular period may be more than the amount of net investment income from that period. As a result, all or a portion of a distribution may be a return of capital, which is in effect a partial return of the amount a common shareholder invested in the Fund, up to the amount of the common shareholder's tax basis in their common shares, which would reduce such tax basis. Although a return of capital may not be taxable, it will generally increase the common shareholder's potential gain, or reduce the common shareholder's potential loss, on any subsequent sale or other disposition of common shares. Future common share distributions will be made if and when declared by the Fund's Board of Trustees, after the evaluation of several factors, including the Fund's net investment income, financial performance and available cash. There can be no assurance that the amount or timing of common share distributions in the future will be equal or similar to that described herein or that the Board of Trustees will not decide to suspend or discontinue the payment of common share distributions in the future. The Fund's objective is to achieve a high level of current income and current capital gains, with long-term capital appreciation as a secondary objective. The Fund intends to pursue its objective by investing in a portfolio of common stocks and utilizing an option strategy, primarily by writing (selling) covered call options on a substantial portion of the common stocks in the portfolio in order to generate current income and gains from option writing premiums and, to a lesser extent, from dividends. Market action can impact dividend issuance as the Fund's total assets affect the Fund's future dividend prospects. The Fund provides additional information on its website at . About XA Investments XA Investments LLC ('XAI') serves as the Fund's investment adviser. XAI is a Chicago-based firm founded by XMS Capital Partners in 2016. XAI serves as the investment adviser for two listed closed-end funds and an interval closed-end fund. The listed closed-end funds, the XAI Octagon Floating Rate & Alternative Income Trust and XAI Madison Equity Premium Income Fund both trade on the New York Stock Exchange and the interval fund, Octagon XAI CLO Income Fund is available via direct subscription and through select broker/dealers and wealth management platforms. In addition to investment advisory services, the firm also provides investment fund structuring and consulting services focused on registered closed-end funds to meet institutional client needs. XAI offers custom product build and consulting services, including development and market research, sales, marketing, and fund management. XAI believes that the investing public can benefit from new vehicles to access a broad range of alternative investment strategies and managers. XAI provides individual investors with access to institutional-caliber alternative managers. For more information, please visit . About XMS Capital Partners XMS Capital Partners, LLC, established in 2006, is a global, independent, financial services firm providing M&A, corporate advisory and asset management services to clients. It has offices in Chicago, Boston and London. For more information, please visit . About Madison Investments Madison Investments is an independent investment management firm based in Madison, WI. The firm was founded in 1974, has approximately $28.3 billion in assets under management as of March 31, 2025, and is recognized as one of the nation's top investment firms. Madison offers domestic fixed income, U.S. and international equity, covered call, multi-asset, insurance and credit union investment management strategies. For more information, please visit .Madison and/or Madison Investments is the unifying tradename of Madison Investment Holdings, Inc., Madison Asset Management, LLC, and Madison Investment Advisors, LLC. Madison Funds are distributed by MFD Distributor, LLC. Madison is registered as an investment adviser with the U.S. Securities and Exchange Commission. MFD Distributor, LLC is registered with the U.S. Securities and Exchange Commission as a broker-dealer and is a member firm of the Financial Industry Regulatory Authority . XAI does not provide tax advice; please consult a professional tax advisor regarding your specific tax situation. Income may be subject to state and local taxes, as well as the federal alternative minimum tax. Investors should consider the investment objectives and policies, risk considerations, charges and expenses of the Fund carefully before investing. For more information on the Fund, please visit the Fund's webpage at . This press release shall not constitute an offer to sell or a solicitation to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer or solicitation or sale would be unlawful prior to registration or qualification under the laws of such state or jurisdiction. NOT FDIC INSURED NO BANK GUARANTEE MAY LOSE VALUE Media Contact:Kimberly Flynn, PresidentXA Investments LLCPhone: 888-903-3358Email: KFlynn@ in to access your portfolio
Yahoo
13 minutes ago
- Yahoo
US securities regulator announces AI task force
(Reuters) -The U.S. Securities and Exchange Commission said on Friday that it is creating an artificial intelligence task force to lead the agency's efforts to "enhance innovation and efficiency" in its operations. Valerie Szczepanik, who has been named the SEC's chief AI officer, will lead the task force, the regulator said in a statement. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
13 minutes ago
- Yahoo
Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the closing of its underwritten public offering of 43,700,000 shares of its common stock, which includes the full exercise of the underwriters' option to purchase 5,700,000 additional shares of its common stock, at a public offering price of $3.30 per share. The underwriters did not receive any discounts or commissions with respect to an aggregate of 1,818,181 shares of common stock sold to the Cystic Fibrosis Foundation. All of the shares of common stock in the offering were sold by Prime Medicine. The gross proceeds to Prime Medicine from the offering, before deducting underwriting discounts and commissions and offering expenses, were approximately $144.2 million. TD Cowen and BMO Capital Markets acted as joint book-running managers for the offering. The shares of common stock were offered by Prime Medicine pursuant to an effective shelf registration statement on Form S-3 that was previously filed with the U.S. Securities and Exchange Commission (SEC) on November 3, 2023 and declared effective by the SEC on November 13, 2023 (File No. 333-275321). The offering was made only by means of a written prospectus and prospectus supplement that form a part of the registration statement. A final prospectus supplement relating to and describing the terms of the offering was filed with the SEC and is available on the SEC's website at Copies of the final prospectus supplement and the accompanying prospectus relating to the offering may be obtained from TD Securities (USA) LLC, 1 Vanderbilt Avenue, New York, New York 10017, by telephone at (855) 495-9846, or by email at or BMO Capital Markets Corp., Attention: Equity Syndicate Department, 151 West 42nd Street, 32nd Floor, New York, New York 10036, by email at bmoprospectus@ This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction. About Prime Medicine Prime Medicine is a leading biotechnology company dedicated to creating and delivering the next generation of gene editing therapies to patients. The Company is deploying its proprietary Prime Editing platform, a versatile, precise and efficient gene editing technology, to develop a new class of differentiated one-time curative genetic therapies. Prime Editors are designed to make only the right edit at the right position within a gene while minimizing unwanted DNA modifications. Prime Medicine is currently progressing a diversified portfolio of investigational therapeutic programs organized around our core areas of focus: liver, lung, and immunology and oncology. Across each core area, Prime Medicine is focused initially on a set of high value programs, each targeting a disease with well-understood biology and a clearly defined clinical development and regulatory path. Investor and Media ContactsGregory DearbornPrime Medicine857-209-0696gdearborn@ Hannah DeresiewiczPrecision
